Free Trial
→ Here's the last trade you should make before heading out for the weekend tomorrow. (From Timothy Sykes) (Ad) Free RCKT Stock Alerts

Rocket Pharmaceuticals (RCKT) SEC Filings & 10K Form

Rocket Pharmaceuticals logo
$2.90 +0.02 (+0.56%)
Closing price 07/3/2025 03:49 PM Eastern
Extended Trading
$2.89 -0.01 (-0.21%)
As of 07/3/2025 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Rocket Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
07/03/2025
2:17 PM		Ondrey Aaron (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2025
3:52 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
6:43 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/27/2025
6:40 AM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
2:13 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:15 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:17 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:21 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:29 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:32 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:18 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
8:59 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
9:02 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
04/30/2025
3:14 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form DEF 14A
04/30/2025
3:15 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form DEFA14A
04/30/2025
3:16 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form ARS
04/22/2025
2:17 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/14/2025
5:57 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
4:10 PM		MAVERICK CAPITAL LTD (Filed by)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form SCHEDULE 13G
04/10/2025
3:07 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
2:26 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2025
3:06 PM		Ondrey Aaron (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:24 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
2:25 PM		Ondrey Aaron (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:01 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Schwartz Jonathan David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:01 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
11:56 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:29 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:09 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:25 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/05/2025
6:47 PM		Pratumsuwan Piratip (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:43 PM		Pratumsuwan Piratip (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2025
2:15 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
8:28 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
2:33 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:38 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
RTW INVESTMENTS, LP (Reporting)
WONG RODERICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:51 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13D/A
12/12/2024
5:02 AM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 424B5
11/25/2024
3:05 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
11/25/2024
3:05 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:26 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:06 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:58 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:27 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
3:15 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
9:52 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:45 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
2:24 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:34 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
4:05 PM		Bjork Elisabeth (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:07 PM		Dolsten Mikael (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:05 PM		Dolsten Mikael (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
3:06 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:26 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
2:29 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:39 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:16 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:23 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:15 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
3:05 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:22 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:05 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
White Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
2:17 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RCKT) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...
American Alternative | Sponsored
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored